LPN "COVID-19 Diagnostic Kit, European Supply Contract Imminent"

[Asia Economy Reporter Yoo Hyun-seok] LPEN, which will become the largest shareholder of KOSDAQ-listed company JMI on the 26th, announced on the 17th that it is negotiating contracts for orders of COVID-19 diagnostic kits with hospitals and local subsidiaries in European countries such as Italy, France, and Germany.

On the 11th, LPEN signed an overseas sales contract with Solgent, which developed the COVID-19 diagnostic kit. LPEN plans to conduct overseas sales through JMI, one of its overseas special distributors.

A company official stated, “As inquiries for diagnostic kit supply are flooding in from overseas, we will utilize the global network possessed by LPEN and JMI to sell to various countries.” He added, “Contracts with hospitals and local subsidiaries in Italy are imminent, and we are also in close discussions with subsidiaries in France and Germany.”

LPEN will pay the remaining acquisition funds for JMI on the 26th and become the largest shareholder.

This content was produced with the assistance of AI translation services.